Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.154 -0.106 (-1.47%)
Streaming Delayed Price Updated: 3:30 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Bausch Health Announces Filing of Supplement to Proxy Statement
Via ACCESS Newswire
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
Via ACCESS Newswire
Bausch Health Announces Adoption of Shareholder Rights Plan
Via ACCESS Newswire
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
Via ACCESS Newswire
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Via ACCESS Newswire
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Via ACCESS Newswire
Earnings Scheduled For February 19, 2025
 
Via Benzinga
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Via ACCESS Newswire
Bausch Health to Announce First Quarter Results on April 30
Via ACCESS Newswire
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
Via ACCESS Newswire
Bausch Health Announces Conditional Redemption of Senior Notes
Via ACCESS Newswire
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
Via ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
Via ACCESS Newswire
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
Via ACCESS Newswire
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises
The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China. 
Via Stocktwits
Topics Earnings
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance
Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report: 
Via Benzinga
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Via ACCESS Newswire
Bausch Health Provides Update on Strategic Alternatives
Via ACCESS Newswire
Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session
 
Via Benzinga
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Via ACCESS Newswire
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Via ACCESS Newswire
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Via ACCESSWIRE
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt
Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value. 
Via Benzinga
Topics Supply Chain
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Via ACCESSWIRE
Bausch Health Appoints New Chief Medical Officer and Head of R&D
Via ACCESSWIRE
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Via ACCESSWIRE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.